Efficacy and safety of developing directacting antiviral agents for treatment of chronic hepatitis C: guidance from FDA and EMA
Author:
Affiliation:

Clc Number:

R512.6+3

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Reference
    Related
Get Citation

易盼盼,戴菱菱,徐平声,等.慢性丙型肝炎直接抗病毒药物临床试验的有效性和安全性研究
——美国FDA和欧洲EMA指南解读[J].中国感染控制杂志英文版,2014,13(11):698-701. DOI:10.3969/j. issn.1671-9638.2014.11.017.
YI Panpan, DAI Lingling, XU Pingsheng, et al. Efficacy and safety of developing directacting antiviral agents for treatment of chronic hepatitis C: guidance from FDA and EMA[J]. Chin J Infect Control, 2014,13(11):698-701. DOI:10.3969/j. issn.1671-9638.2014.11.017.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 17,2014
  • Revised:October 08,2014
  • Adopted:
  • Online: November 30,2014
  • Published: